Orange Book product · Brand (NDA)
SEYSARA
SARECYCLINE HYDROCHLORIDE
At a glance
Oct 01, 2018
Approved
Brand (NDA)
Application
Not listed
TE code
5
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 01, 2018
7 yr 10 mo ago
Today
Patent 9481639 expires
Listed method-of-use patent (U-2409) expiration.
Aug 10, 2028
in 2 yr 2 mo
Patent 8513223 expires
Listed method-of-use patent (U-2406) expiration.
Dec 07, 2029
in 3 yr 6 mo
Patent 8318706 expires
Listed drug substance patent expiration.
Jan 03, 2032
in 5 yr 7 mo
Patent 9255068 expires
Listed drug substance patent expiration.
Feb 09, 2033
in 6 yr 9 mo
Patent 9255068 expires
Listed drug substance patent expiration.
Feb 09, 2033
in 6 yr 9 mo
Pharmaceutical detail
Active ingredient
SARECYCLINE HYDROCHLORIDE
Strength
EQ 60MG BASE
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 209521
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (5)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9481639 | Aug 10, 2028 | in 2 yr 2 mo | U-2409 |
| 8513223 | Dec 07, 2029 | in 3 yr 6 mo | U-2406 |
| 8318706 | Jan 03, 2032 | in 5 yr 7 mo | SubstanceProductU-2405 |
| 9255068 | Feb 09, 2033 | in 6 yr 9 mo | SubstanceProductU-2407 |
| 9255068 | Feb 09, 2033 | in 6 yr 9 mo | SubstanceProductU-2408 |
